loading...| Preferred Name |
Ulipristal Acetate |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91057 |
| CAS_Registry |
126784-99-4 |
| Chemical_Formula |
C30H37NO4 |
| code |
C91057 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
An orally bioavailable, acetate salt of ulipristal, a selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception |
| FDA_UNII_Code |
YF7V70N02B |
| FULL_SYN |
Ella VA-2914 PGL-4001 RTI-3021-012 17-alpha-acetoxy-11-beta-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione 11-beta-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione CDB-2914 |
| label |
Ulipristal Acetate |
| PDQ_Closed_Trial_Search_ID |
729448 |
| PDQ_Open_Trial_Search_ID |
729448 |
| Preferred_Name |
Ulipristal Acetate |
| prefixIRI |
C91057 |
| prefLabel |
Ulipristal Acetate |
| PubMedID_Primary_Reference |
22296076 |
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
| UMLS_CUI |
C2723461 |
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.obolibrary.org/obo/CHEBI_71025 | Chemical Entities of Biological Interest Ontology | LOOM | |
| http://purl.bioontology.org/ontology/MESH/C555622 | Medical Subject Headings | LOOM |